Hepatic leukocyte immunoglobulin‐like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1‐TRAF6 pathway

Nonalcoholic fatty liver disease (NAFLD) is an increasingly prevalent liver pathology characterized by hepatic steatosis and commonly accompanied by systematic inflammation and metabolic disorder. Despite an accumulating number of studies, no pharmacological strategy is available to treat this condi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yao, Jiang, Zhou, Dai, Haijiang, Miao, Rujia, Shu, Jingxian, Gu, Haotian, Liu, Xing, Huang, Zhijun, Yang, Guoping, Chen, Alex F., Yuan, Hong, Li, Ying, Cai, Jingjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900726/
https://www.ncbi.nlm.nih.gov/pubmed/29091299
http://dx.doi.org/10.1002/hep.29633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900726/
https://www.ncbi.nlm.nih.gov/pubmed/29091299
http://dx.doi.org/10.1002/hep.29633

Ejemplares similares